Výsledky vyhledávání - "T. K. Schramm"

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

Autor: Torp-Pedersen Ct, Jonas Bjerring Olesen, Steen Z. Abildstrom, Peter Riis Hansen, Peter Weeke, Casper H. Jørgensen, Allan Vaag, Charlotte Andersson, G. H. Gislason, Mette Lykke Norgaard, Theis Lange, Lars Køber, T. K. Schramm

Publikováno v: Diabetologia. 53:2546-2553

The safety of metformin in heart failure has been questioned because of a perceived risk of life-threatening lactic acidosis, though recent studies have not supported this concern. We investigated the risk of all-cause mortality associated with indiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eed4232a1f3fa3e274a43ed9a15d7c70
https://doi.org/10.1007/s00125-010-1906-6

Zobrazit plný text záznamu

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

Autor: Lars Køber, C. H. Jørgensen, T. K. Schramm, Charlotte Andersson, Mette Lykke Norgaard, Gunnar Gislason, Fredrik Folke, Morten Lock Hansen, Allan Vaag, Søren Andersen, Christian Torp-Pedersen, D. M. Bretler

Publikováno v: Diabetologia. 53:1612-1619

We assessed secular trends of cardiovascular outcomes following first diagnosis of myocardial infarction (MI) or diabetes in an unselected population.All Danish residents agedor = 30 years without prior diabetes or MI were identified by individual-le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb29dc75063f5b1f75749af9cad8bce
https://doi.org/10.1007/s00125-010-1783-z

Zobrazit plný text záznamu

Initiation and Persistence to Statin Treatment in Patients with Diabetes Receiving Glucose-Lowering Medications 1997- 2006

Autor: Torp-Pedersen Ct, Henrik E. Poulsen, Steen Zabell Abildstrøm, Helena Dominguez, G. H. Gislason, T.J. Guterbaum, Casper H. Jørgensen, Mette Lykke Norgaard, Lars Køber, T. K. Schramm

Publikováno v: The Open Cardiovascular Medicine Journal

Aims:Since 2001 guidelines recommend statin treatment in most patients with diabetes. We investigated secular changes in initiation and persistence to statin treatment during a 10-year period in a nationwide cohort of patients initiating glucose-lowe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46917f83733b4f2fb55a841ee094eaf
https://doi.org/10.2174/1874192400903010152

Zobrazit plný text záznamu

Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation

Autor: Niels Gadsbøll, Lars Køber, T. K. Schramm, Torp-Pedersen Ct, Emil L. Fosbøl, Rikke Sørensen, Morten Lock Hansen, Henrik E. Poulsen, Søren Andersen, Mette Madsen, Fredrik Folke, Søren K. Rasmussen, Gunnar Gislason, Steen Zabell Abildstrøm

Publikováno v: Hansen, M L, Gadsbøll, N, Rasmussen, S, Gislason, G H, Folke, F, Andersen, S S, Schramm, T K, Sørensen, R, Andersen, S S, Abildstrøm, S Z, Madsen, M, Poulsen, H E, Køber, L & Andersen, S S 2009, ' Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation ', Journal of Internal Medicine, vol. 265, no. 3, pp. 335-44 . https://doi.org/10.1111/j.1365-2796.2008.02061.x

Hansen ML, Gadsboll N, Rasmussen S, Gis-lason GH, Folke F, Andersen SS, Schramm TK,Sorensen R, Fosbol EL, Abildstrom SZ, Madsen M,Poulsen HE, Kober L, Torp-Pedersen C (GentofteUniversity Hospital, Hellerup; Sygehus Nord, Koge;National Institute of Pu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60235f142b1659230a51664c0feb7007
https://portal.findresearcher.sdu.dk/da/publications/87ffb8b0-a35e-11de-9743-000ea68e967b

Zobrazit plný text záznamu

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

Autor: G. H. Gislason, Lars Køber, Jeppe Nørgaard Rasmussen, Morten Lock Hansen, Emil L. Fosbøl, T. K. Schramm, J Traerup, Henrik E. Poulsen, Fredrik Folke, Rikke Sørensen, Christian Torp-Pedersen, Steen Z. Abildstrom, Susan Andersen, Søren K. Rasmussen, Søren Jacobsen

Publikováno v: Fosbøl, E L, Gislason, G H, Jacobsen, S, Folke, F, Hansen, M L, Schramm, T K, Sørensen, R, Rasmussen, J N, Andersen, S S, Abildstrøm, S, Traerup, J, Poulsen, H E, Rasmussen, S, Køber, L & Torp-Pedersen, C 2009, ' Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study ', Clinical Pharmacology and Therapeutics, vol. 85, no. 2, pp. 190-197 . https://doi.org/10.1038/clpt.2008.204

Use of some nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with increased cardiovascular risk in several patient groups, but whether this excess risk exists in apparently healthy individuals has not been clarified. Using a historical coh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cb846f0a67b299f33d3ac6bc13ecb8
https://pubmed.ncbi.nlm.nih.gov/19865082

Zobrazit plný text záznamu

DPP-4 inhibitors and GLP-1 agonists in type 2 diabetes - early assessment of cardiovascular safety in a nationwide setting

Autor: Lars Køber, Charlotte Andersson, Nikolai Madrid Scheller, T. K. Schramm, Gunnar Gislason, A. Vaag, C.T Pedersen, Emil L. Fosbøl, Ulrik M. Mogensen

Publikováno v: Mogensen, U M, Andersson, C, Fosbol, E L, Schramm, T K, Vaag, A, Scheller, N M, Torp-Pedersen, C, Gislason, G & Kober, L 2013, ' DPP-4 inhibitors and GLP-1 agonists in type 2 diabetes : Early assessment of cardiovascular safety in a nationwide setting ', European Heart Journal, vol. 34, no. 1. Supplement, 5929, pp. 1111 . https://doi.org/10.1093/eurheartj/eht311.5929

Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors and Glucagon Like Peptide-1 (GLP-1) agonists have recently been introduced in the treatment of type 2 diabetes and are mainly used as add-on therapy to metformin, either alone or with additional s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f357fb927d68a82f0f4f50dd736a5f36
https://doi.org/10.1093/eurheartj/eht311.5929

Zobrazit plný text záznamu

Differences in mortality and cardiovascular risk associated with insulin in combination with individual insulin secretagogues or metformin - a nationwide study

Autor: Charlotte Andersson, Lars Køber, Christian Torp-Pedersen, Emil L. Fosbøl, Ulrik M. Mogensen, Nikolai Madrid Scheller, T. K. Schramm, A. Vaag, Gunnar Gislason

Publikováno v: Mogensen, U M, Andersson, C, Fosbol, E L, Schramm, T K, Vaag, A, Scheller, N M, Torp-Pedersen, C, Gislason, G & Kober, L 2013, ' Differences in mortality and cardiovascular risk associated with insulin in combination with indi vidual insulin secreta gogues or metformin : A nationwide study ', European Heart Journal, vol. 34, no. 1. Supplement, P4251, pp. 784 . https://doi.org/10.1093/eurheartj/eht309.P4251

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8582aba0b38921692e35ddc8bef0ba9
https://doi.org/10.1093/eurheartj/eht309.p4251

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání